Cargando...
Tumour heterogeneity and the evolution of polyclonal drug resistance
Cancer drug resistance is a major problem, with the majority of patients with metastatic disease ultimately developing multidrug resistance and succumbing to their disease. Our understanding of molecular events underpinning treatment failure has been enhanced by new genomic technologies and pre‐clin...
Guardado en:
| Publicado en: | Mol Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528620/ https://ncbi.nlm.nih.gov/pubmed/25087573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.06.005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|